The report on heparin market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global heparin market over the period of 2015 to 2023. Moreover, the report is collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global heparin market over the period of 2015 to 2023. Further, Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.
Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents.
The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through:
1. Key Opinion Leaders associated
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers
Primary research respondents typically include:
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.
Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
Secondary sources of the data typically include:
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
The global heparin market is segmented on the basis of type of product, route of administration, application and end users.
Global Heparin Market by Type of Product
- Low Molecular Weight Heparin
- Unfractionated Heparin
- Ultra-low Molecular Weight Heparin
- IV Injection
- Subcutaneous Injection
- Clinical Trials
- Medical Devices
- Venous Thromboembolism
- Blood and Stem Cell Bank
- Sanofi SA
- GlaxoSmithKline plc
- Leo Pharma
- Dr. Reddy’s Laboratories
- Fresenius SE & Co. KG
- Teva Pharmaceutical Industries Ltd.
- Baxter International
- Aspen Holdings
1. Comprehensive analysis of global as well as regional markets of heparin market.
2. Complete coverage of all the segments in Heparin Market to analyze the trends, developments in the global market and forecast of market size up to 2023.
3. Comprehensive analysis of the companies operating in global Heparin Market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Global Heparin Market Overview
3.2. Market Dynamics
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.5. Competitive Landscape in the Global Heparin Market
4. Global Heparin Market by Type of Product
4.1. Low Molecular Weight Heparin
4.2. Unfractionated Heparin
4.3. Ultra-low Molecular Weight Heparin
5. Global Heparin Market by Route of Administration
5.1. IV Injection
5.2. Subcutaneous Injection
6. Global Heparin Market by Applications
6.1. Clinical Trials
6.2. Medical Devices
6.3. Venous Thromboembolism
7. Global Heparin Market by End Users
7.2. Blood and Stem Cell Bank
8. Global Heparin Market by Region 2017-2023
8.1. North America
8.1.1. North America Heparin Market by Type of Product
8.1.2. North America Heparin Market by Route of Administration
8.1.3. North America Heparin Market by Applications
8.1.4. North America Heparin Market by End Users
8.1.5. North America Heparin Market by Country
8.2.1. Europe Heparin Market by Type of Product
8.2.2. Europe Heparin Market by Route of Administration
8.2.3. Europe Heparin Market by Applications
8.2.4. Europe Heparin Market by End Users
8.2.5. Europe Heparin Market by Country
8.3.1. Asia-Pacific Heparin Market by Type of Product
8.3.2. Asia-Pacific Heparin Market by Route of Administration
8.3.3. Asia-Pacific Heparin Market by Applications
8.3.4. Asia-Pacific Heparin Market by End Users
8.3.5. Asia-Pacific Heparin Market by Country
8.4.1. RoW Heparin Market by Type of Product
8.4.2. RoW Heparin Market by Route of Administration
8.4.3. RoW Heparin Market by Applications
8.4.4. RoW Heparin Market by End Users
8.4.5. RoW Heparin Market by Sub-region
9. Company Covered
9.1. Sanofi SA
9.2. GlaxoSmithKline plc
9.4. Leo Pharma
9.5. Dr. Reddy’s Laboratories
9.6. Fresenius SE & Co. KG
9.7. Teva Pharmaceutical Industries Ltd.
9.8. Baxter International
9.9. Aspen Holdings